AI assistant
TRANSENSE TECHNOLOGIES PLC Director's Dealing 2023
7985_dirs_2023-11-09_b4404234-cc79-46b8-bce5-74ec2e9dbf92.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 9783S
Transense Technologies PLC
09 November 2023
9 November 2023
Transense Technologies plc
("Transense" or the "Company")
Director/PDMR shareholding - acquisition of shares
Transense Technologies plc (AIM: TRT), the developer of specialist sensor systems, has been notified that Ryan Maughan, Business Development Director, has today purchased 1,651 ordinary shares of 10 pence each in the Company ("Ordinary Shares") at a price of 102.5 pence per share.
Accordingly, Ryan Maughan's total beneficial shareholding in the Company has increased to 24,861 Ordinary Shares, which represents approximately 0.16% of the Company's current voting rights.
Further details are provided in the forms below in accordance with the requirements of the UK Market Abuse Regulation.
For further information please visit www.transense.com or contact:
| Transense Technologies plc Nigel Rogers (Executive Chairman) Melvyn Segal (CFO) |
Tel: Via Walbrook PR |
| Allenby Capital (Nominated Adviser and Broker) Jeremy Porter/George Payne (Corporate Finance) Tony Quirke/Stefano Aquilino (Sales & Corporate Broking) |
Tel: +44 (0)20 3328 5656 |
| Walbrook PR Tom Cooper/Nick Rome |
Tel: +44 (0)20 7933 8780 [email protected] |
Notes to Editors:
Transense is a developer of specialist wireless sensor systems used to enable real-time data gathering and monitoring. Products include the patent protected Surface Acoustic Wave (SAW) sensor technology, used to improve equipment power, performance, reliability and efficiency; iTrack, Transense 's Tyre Pressure Monitoring System, licensed to Bridgestone Corporation, the world's largest tyre producer, under a ten-year deal in June 2020; and a range of intelligent tyre monitoring equipment under the Translogik brand. Target sectors include aerospace, electric motors & drives, industrial machinery and performance automotive.
The Company's strategy is to maximise shareholder value through the delivery of sustained revenue growth from all three principal technologies - SAW, iTrack and Translogik probes - through leveraging excellence in innovation, know-how in commercialising technologies, industry partnerships and exposure to global growth markets.
Transense is headquartered in Oxfordshire, UK, and was admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999. www.transense.com
For further information please contact [email protected] .
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Ryan Maughan |
| 2 | Reason for the notification | |
| a) | Position/status | Business Development Director |
| b) | Initial notification /Amendment | Initial |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Transense Technologies plc |
| b) | LEI | 2138005N52J6KKQ3EY67 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument | Ordinary Shares of 10 pence each |
| Identification code | GB00BDHDTH21 | |
| b) | Nature of the transaction | Purchase of Ordinary Shares |
| c) | Price and volume | Price: 102.5 pence per share Volume: 1,651 |
| d) | Aggregated information | |
| - Aggregated volume | As above | |
| - Price | ||
| e) | Date of the transaction | 9 November 2023 |
| f) | Place of the transaction | London Stock Exchange, AIM |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHFLFLFLILAIIV